General Surgery and Hepato-pancreato-biliary Unit, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
General Surgery and Hepato-pancreato-biliary Unit, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Int J Surg. 2018 Jul;55:103-109. doi: 10.1016/j.ijsu.2018.05.025. Epub 2018 May 25.
The aim of this study is to analyze the evolution of pancreatectomy with venous resection in 10 referral Italian centers in the last 25 years.
A multicenter database of 425 patients submitted to pancreatectomy with venous resection between 1991 and 2015 was retrospectively analyzed. Patients were classified in 5 periods: 1 (1991-1995); 2 (1996-2000); 3 (2001-2005); 4 (2006-2010); 5 (2011-2015). Indications and outcomes were compared according to the period of surgery.
Nineteen patients were operated in period 1, 28 in period 2, 91 in period 3, 140 in period 4, and 147 in period 5. Use of neoadjuvant therapy increased from 0% in period 1 and 2-12.1% in period 5. Postoperative complications ranged from 46.3% to 67.8%, and mortality from 5.3% to 9.2%. Median survival progressively increased, from 6 months in period 1-16 months in period 2, 24 months in period 3 and 4 and 35 months in period 5 (p = 0.004). Period, venous and nodal invasion were significant prognostic factors for survival.
Management and outcomes of pancreatectomy with venous resection have evolved in the last 25 years in Italy. Improvement in patients' multidisciplinary management has lead to significant improvement of median survival.
本研究旨在分析 10 家意大利转诊中心过去 25 年中进行的胰腺切除术联合静脉切除的演变过程。
回顾性分析了 1991 年至 2015 年间接受胰腺切除术联合静脉切除的 425 例患者的多中心数据库。患者分为 5 个时期:1 期(1991-1995 年);2 期(1996-2000 年);3 期(2001-2005 年);4 期(2006-2010 年);5 期(2011-2015 年)。根据手术时间,比较了适应证和结果。
1 期手术 19 例,2 期手术 28 例,3 期手术 91 例,4 期手术 140 例,5 期手术 147 例。新辅助治疗的使用率从第 1 期和第 2 期的 0%上升到第 5 期的 12.1%。术后并发症发生率为 46.3%至 67.8%,死亡率为 5.3%至 9.2%。中位生存期逐渐延长,从第 1 期的 6 个月延长至第 2 期的 16 个月,第 3 期和第 4 期的 24 个月,第 5 期的 35 个月(p=0.004)。分期、静脉和淋巴结侵犯是影响生存的显著预后因素。
在过去的 25 年中,意大利胰腺切除术联合静脉切除的管理和结果发生了演变。患者多学科管理的改善导致中位生存期显著提高。